Gilbert Fuller Sells 1,057 Shares of USANA Health Sciences (NYSE:USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert Fuller sold 1,057 shares of the stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $18.66, for a total value of $19,723.62. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

USANA Health Sciences Stock Performance

Shares of USNA stock opened at $18.77 on Thursday. The stock’s fifty day moving average is $18.26 and its 200-day moving average is $19.47. The stock has a market capitalization of $346.49 million, a PE ratio of 39.94, a PEG ratio of 0.72 and a beta of 0.77. USANA Health Sciences, Inc. has a 52 week low of $16.60 and a 52 week high of $38.32.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.44 by $0.17. The company had revenue of $250.22 million for the quarter, compared to analysts’ expectations of $240.99 million. USANA Health Sciences had a return on equity of 6.21% and a net margin of 0.96%.USANA Health Sciences has set its FY 2026 guidance at 1.950-2.290 EPS. As a group, analysts forecast that USANA Health Sciences, Inc. will post 2.12 earnings per share for the current fiscal year.

Hedge Funds Weigh In On USANA Health Sciences

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. UBS Group AG lifted its holdings in shares of USANA Health Sciences by 252.3% during the 4th quarter. UBS Group AG now owns 138,334 shares of the company’s stock valued at $2,715,000 after purchasing an additional 99,063 shares in the last quarter. Allianz Asset Management GmbH lifted its holdings in shares of USANA Health Sciences by 126.0% during the 3rd quarter. Allianz Asset Management GmbH now owns 47,203 shares of the company’s stock valued at $1,300,000 after purchasing an additional 26,314 shares in the last quarter. Exchange Traded Concepts LLC lifted its holdings in shares of USANA Health Sciences by 11.0% during the 4th quarter. Exchange Traded Concepts LLC now owns 52,411 shares of the company’s stock valued at $1,029,000 after purchasing an additional 5,207 shares in the last quarter. Tudor Investment Corp ET AL bought a new position in shares of USANA Health Sciences during the 3rd quarter valued at about $664,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in shares of USANA Health Sciences during the 3rd quarter valued at about $266,000. Institutional investors own 54.25% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of USANA Health Sciences in a research note on Friday, March 27th. Zacks Research lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 22nd. Finally, Wall Street Zen lowered USANA Health Sciences from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce”.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.